Isomorphic Labs raises $5B to push AI-designed drugs toward human trials

Greenoaks and Sequoia Capital co-led the Series C for Demis Hassabis's Alphabet spinout, six months after its $2.1B Series B. No valuation was disclosed.

By · Published · Updated

Text reads, “We’ve closed our $5 Billion Series C funding round co-led by Greenoaks and Sequoia Capital.”

Greenoaks and Sequoia Capital co-led the Series C for Demis Hassabis's Alphabet spinout, six months after its $2.1B Series B. No valuation was disclosed.